Intellectual Property India Publishes Patent Application for 'Fused Ring Compound And Pharmaceutical Containing Same' Filed by Kaken Pharmaceutical Co. Ltd.

MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517034362 A) filed by Kaken Pharmaceutical Co. Ltd., Tokyo, on April 8, for 'fused ring compound and pharmaceutical containing same.'

Inventor(s) include Sumikawa Yoshitake; Akahoshi Issei; and Kato Masaya.

The application for the patent was published on April 25, under issue no. 17/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides a novel compound that has an STAT6 inhibitory effect and is efficacious in treating inflammatory diseases and allergic diseases such as atopic dermatitis. A compound represented by general formula (I) and having an STAT6 inhibitory effect or a pharmaceutically...